Fortrea Holdings Inc. (FTRE)
USD 6.33
(-6.77%)
USD 6.33
(-6.77%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.61 Billion USD | 176.99% |
| 2022 | 945.3 Million USD | -14.69% |
| 2021 | 1.1 Billion USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 2.1 Billion USD | -20.54% |
| 2024 Q1 | 2.64 Billion USD | 1.14% |
| 2023 Q4 | 2.61 Billion USD | -0.15% |
| 2023 Q3 | 2.62 Billion USD | 0.66% |
| 2023 Q1 | 2.5 Billion USD | 164.57% |
| 2023 Q2 | 2.6 Billion USD | 4.16% |
| 2023 FY | 2.61 Billion USD | 176.99% |
| 2022 Q4 | 945.3 Million USD | 0.0% |
| 2022 FY | 945.3 Million USD | -14.69% |
| 2021 FY | 1.1 Billion USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AbCellera Biologics Inc. | 335.77 Million USD | -679.806% |
| Alkermes plc | 933.53 Million USD | -180.482% |
| Agenus Inc. | 462.29 Million USD | -466.392% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 35.357% |
| Aptorum Group Limited | 5.25 Million USD | -49710.358% |
| Ardelyx, Inc. | 130.76 Million USD | -1902.401% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | -447.336% |
| Bicycle Therapeutics plc | 224.41 Million USD | -1066.783% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -1910.905% |
| ChromaDex Corporation | 26.5 Million USD | -9777.773% |
| Chimerix, Inc. | 19.74 Million USD | -13161.079% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -7343.476% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -3508.252% |
| CRISPR Therapeutics AG | 346.76 Million USD | -655.087% |
| Precision BioSciences, Inc. | 140.92 Million USD | -1758.076% |
| Dyadic International, Inc. | 2.34 Million USD | -111766.314% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -16000.35% |
| Fortress Biotech, Inc. | 165.93 Million USD | -1477.929% |
| Lantern Pharma Inc. | 2.73 Million USD | -95473.136% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -3563.123% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -74102.439% |
| Incyte Corporation | 1.59 Billion USD | -64.444% |
| IO Biotech, Inc. | 17.55 Million USD | -14814.559% |
| Jaguar Health, Inc. | 45.86 Million USD | -5608.804% |
| Novavax, Inc. | 2.57 Billion USD | -1.793% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -7161.634% |
| Opthea Limited | 264.6 Million USD | -889.564% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -1903.259% |
| ContextLogic Inc. | 206 Million USD | -1171.068% |
| MiMedx Group, Inc. | 96.33 Million USD | -2618.156% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -5352.501% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -74099.032% |
| NextCure, Inc. | 14.99 Million USD | -17359.492% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -64679.812% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -39115.216% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -5502.174% |
| Vaxcyte, Inc. | 167.44 Million USD | -1463.7% |
| PDS Biotechnology Corporation | 33.25 Million USD | -7772.725% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -1013.199% |
| Pharming Group N.V. | 244.07 Million USD | -972.794% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -21862.758% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -1948.971% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -39529.021% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -39529.021% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -3076.398% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -39315.927% |
| Acelyrin, Inc. | 86.35 Million USD | -2932.205% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -201433.049% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -18109.889% |
| Summit Therapeutics Inc. | 125.25 Million USD | -1990.422% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -27523.167% |
| Senti Biosciences, Inc. | 52.57 Million USD | -4880.693% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -3707.087% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -1628.18% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -133765.031% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -195952.005% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -1054.334% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -27853.454% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -1051.223% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | -429.495% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -23891.204% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -9417.647% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -21531.269% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | -438.1% |
| Immix Biopharma, Inc. | 3.72 Million USD | -70253.376% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -6824.786% |
| MEI Pharma, Inc. | 8.35 Million USD | -31239.318% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -8924.298% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -653.323% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -1695.035% |
| Fortress Biotech, Inc. | 165.93 Million USD | -1477.929% |
| Precigen, Inc. | 41.64 Million USD | -6187.58% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -5144.142% |
| AlloVir, Inc. | 45.01 Million USD | -5716.728% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -1908.946% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -1800.145% |
| ImmuCell Corporation | 18.81 Million USD | -13816.537% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -9176.554% |
| Onconetix, Inc. | 23.18 Million USD | -11195.512% |
| PureTech Health plc | 125.58 Million USD | -1984.996% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -29155.866% |
| Elevation Oncology, Inc. | 34.28 Million USD | -7537.827% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -106992.025% |
| Seer, Inc. | 39.36 Million USD | -6551.594% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -4134.564% |
| Innoviva, Inc. | 568.55 Million USD | -360.538% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -9516.571% |
| ESSA Pharma Inc. | 3.49 Million USD | -74816.933% |
| GlycoMimetics, Inc. | 6.9 Million USD | -37836.423% |
| GT Biopharma, Inc. | 6.63 Million USD | -39375.351% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -890.355% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -861.632% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -3016.178% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -26689.441% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -9537.454% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -81071.242% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -3449.555% |
| Aptose Biosciences Inc. | 15.8 Million USD | -16463.031% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -23618.066% |
| Soligenix, Inc. | 7.27 Million USD | -35892.228% |
| Century Therapeutics, Inc. | 175.94 Million USD | -1388.226% |
| Kura Oncology, Inc. | 51.66 Million USD | -4968.329% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -2058.935% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -63253.496% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -39489.619% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -936.588% |
| Autolus Therapeutics plc | 263.9 Million USD | -892.168% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -24879.966% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -2846.625% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -5483.061% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -642.059% |
| GRI Bio, Inc. | 2.69 Million USD | -96985.651% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -323324.965% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -8321.73% |
| IGM Biosciences, Inc. | 220.17 Million USD | -1089.225% |
| INmune Bio, Inc. | 18.86 Million USD | -13781.879% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -920.902% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -9728.16% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -96221.153% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -79722.795% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -4379.343% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -2622.99% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -889.065% |
| Coherus BioSciences, Inc. | 823.02 Million USD | -218.142% |
| Verastem, Inc. | 71.18 Million USD | -3578.303% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -5224.549% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -6687.288% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -5251.099% |
| Histogen Inc. | 5.69 Million USD | -45861.032% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -59604.419% |
| Surrozen, Inc. | 8.14 Million USD | -32047.33% |
| Organovo Holdings, Inc. | 2.74 Million USD | -95183.843% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -834162.628% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -4556.598% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -15757.558% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -5023.77% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -316562.132% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -1966.206% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -24113.975% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -1635.315% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -100323.995% |
| Apollomics, Inc. | 14.15 Million USD | -18400.671% |
| Amarin Corporation plc | 279.58 Million USD | -836.524% |
| Mesoblast Limited | 188.79 Million USD | -1286.879% |
| Turnstone Biologics Corp. | 14.14 Million USD | -18407.209% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -1348.326% |
| Synaptogenix, Inc. | 5.52 Million USD | -47253.552% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -39286.282% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -1439.257% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -30498.819% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -148893.424% |
| Exelixis, Inc. | 678.44 Million USD | -285.941% |
| Better Therapeutics, Inc. | 23.84 Million USD | -10882.3% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -1496.138% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | -340.653% |
| NLS Pharmaceutics AG | 10.68 Million USD | -24416.386% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -161169.66% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -6626.437% |
| Gritstone bio, Inc. | 125.91 Million USD | -1979.432% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -17741.374% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -51355.923% |
| Avid Bioservices, Inc. | 275.66 Million USD | -849.838% |
| Insmed Incorporated | 1.66 Billion USD | -57.568% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -33931.607% |
| MediWound Ltd. | 27.18 Million USD | -9531.074% |
| OmniAb, Inc. | 87.4 Million USD | -2895.881% |
| Alector, Inc. | 487.66 Million USD | -436.922% |
| Seres Therapeutics, Inc. | 403.45 Million USD | -548.993% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -14111.126% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -6723.548% |
| Zai Lab Limited | 240.17 Million USD | -990.196% |
| Revance Therapeutics, Inc. | 630.05 Million USD | -315.581% |
| Aura Biosciences, Inc. | 29.22 Million USD | -8858.839% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -2653.978% |
| Immunic, Inc. | 25.36 Million USD | -10221.665% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -3681.848% |
| Veracyte, Inc. | 93.71 Million USD | -2693.884% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -99966.0% |
| FibroGen, Inc. | 585.72 Million USD | -347.033% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -14962.993% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -400833.429% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -46198.638% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 65.801% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -31839.497% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -3016.327% |
| TG Therapeutics, Inc. | 169.08 Million USD | -1448.57% |
| Galecto, Inc. | 5.89 Million USD | -44309.769% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -31507.919% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -8984.727% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -20646.375% |
| XBiotech Inc. | 8.39 Million USD | -31082.565% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -17741.374% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -4823.656% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -621.112% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -9639.622% |
| Theravance Biopharma, Inc. | 169 Million USD | -1449.312% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | -115.4% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | -423.234% |
| Vaxxinity, Inc. | 30.94 Million USD | -8361.737% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | -169.248% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -43314.915% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | -251.353% |
| NexImmune, Inc. | 5.08 Million USD | -51400.404% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -704919.467% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -85055.429% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 63.158% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -50702.964% |
| Scopus BioPharma Inc. | 7.45 Million USD | -35025.403% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -9858.165% |
| Ainos, Inc. | 7.39 Million USD | -35311.429% |
| Pluri Inc. | 34.11 Million USD | -7575.891% |
| Prothena Corporation plc | 135.01 Million USD | -1839.311% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -977.074% |
| Celularity Inc. | 102.92 Million USD | -2443.889% |
| Rallybio Corporation | 9.43 Million USD | -27649.046% |
| Cue Biopharma, Inc. | 24.44 Million USD | -10611.393% |
| MeiraGTx Holdings plc | 319.99 Million USD | -718.273% |
| Omeros Corporation | 403.25 Million USD | -549.321% |
| Humacyte, Inc. | 114.67 Million USD | -2183.283% |
| Immunocore Holdings plc | 228.15 Million USD | -1047.626% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -53610.769% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -3312.041% |
| Blueprint Medicines Corporation | 918.64 Million USD | -185.03% |
| CalciMedica, Inc. | 4.02 Million USD | -64904.965% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -14903.438% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -1598.682% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -2951.144% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -842.572% |
| Pulmatrix, Inc. | 15.96 Million USD | -16302.932% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -16500.52% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -10541.307% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -943.986% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -5055.751% |
| Cytokinetics, Incorporated | 1.21 Billion USD | -116.282% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -8138.366% |
| Nutriband Inc. | 1.07 Million USD | -242587.357% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -24525.223% |
| Vor Biopharma Inc. | 59.1 Million USD | -4330.157% |
| Roivant Sciences Ltd. | 773.95 Million USD | -238.315% |
| Evogene Ltd. | 17.99 Million USD | -14454.753% |
| ProKidney Corp. | 29.21 Million USD | -8862.212% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -3537.728% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -371313.211% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | -38.619% |
| CorMedix Inc. | 11.91 Million USD | -21870.999% |
| BioLineRx Ltd. | 50.7 Million USD | -5064.293% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -1651.919% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -2860.618% |
| Atai Life Sciences N.V. | 49.16 Million USD | -5226.065% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -8305.156% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -14477.441% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -2000.838% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -46210.577% |
| MediciNova, Inc. | 3.89 Million USD | -67184.192% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -14224.635% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -173967.852% |
| GeoVax Labs, Inc. | 3.51 Million USD | -74288.878% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -559.117% |
| Biomea Fusion, Inc. | 30.69 Million USD | -8431.769% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 3.797% |
| Mereo BioPharma Group plc | 15.96 Million USD | -16303.959% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -8292.039% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -4361.864% |
| Absci Corporation | 58.3 Million USD | -4390.944% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -13646.325% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -8066.677% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -3448.448% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -2893.039% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -7653.627% |
| Allakos Inc. | 74.79 Million USD | -3400.862% |
| Imunon, Inc. | 8.53 Million USD | -30594.829% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -11536.816% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -2180.598% |
| BioAtla, Inc. | 48.98 Million USD | -5245.201% |
| NLS Pharmaceutics AG | 10.68 Million USD | -24416.386% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -94120.943% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -1904.839% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -18319.979% |
| XOMA Corporation | 145.58 Million USD | -1698.599% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -7677.811% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -3708.083% |
| aTyr Pharma, Inc. | 31.59 Million USD | -8186.863% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -4135.317% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -5723.196% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -5309.694% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -91133.449% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -31996.031% |
| Akari Therapeutics, Plc | 4.58 Million USD | -57020.419% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -14665.583% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | -58.743% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -648166.437% |
| UroGen Pharma Ltd. | 243.52 Million USD | -975.217% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -715.48% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -94716.042% |
| Orgenesis Inc. | 35.53 Million USD | -7268.51% |
| Entera Bio Ltd. | 1.37 Million USD | -189776.722% |
| GH Research PLC | 6.7 Million USD | -38974.765% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -38405.882% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -13808.425% |
| Xencor, Inc. | 283.55 Million USD | -823.406% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -87598.762% |
| Replimune Group, Inc. | 113.21 Million USD | -2212.788% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -69591.586% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -2429.122% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -648166.437% |
| Portage Biotech Inc. | 4.45 Million USD | -58740.449% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -173967.852% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -11259.653% |
| OncoCyte Corporation | 49.29 Million USD | -5211.372% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -63195.224% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -328232.606% |
| Purple Biotech Ltd. | 10 Million USD | -26070.915% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -45154.062% |
| scPharmaceuticals Inc. | 57.26 Million USD | -4472.746% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -21036.548% |
| HilleVax, Inc. | 78.9 Million USD | -3218.253% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -51749.505% |
| Tharimmune, Inc. | 1.81 Million USD | -144160.807% |
| Genprex, Inc. | 3.25 Million USD | -80361.974% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -9555.223% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -49907.639% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -1270967.961% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -730178.791% |
| OKYO Pharma Limited | 7.42 Million USD | -35184.387% |
| Savara Inc. | 37.19 Million USD | -6940.224% |
| Curis, Inc. | 57.61 Million USD | -4444.886% |
| Daré Bioscience, Inc. | 26.32 Million USD | -9844.605% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -6579.627% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -181229.64% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -12476.973% |
| BeiGene, Ltd. | 2.23 Billion USD | -17.22% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -12198.847% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -897.877% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -12207.982% |
| Erasca, Inc. | 78.61 Million USD | -3230.832% |
| bluebird bio, Inc. | 424.62 Million USD | -516.64% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -399501.985% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | -38.536% |
| DBV Technologies S.A. | 42.8 Million USD | -6017.757% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -399501.985% |
| Moderna, Inc. | 4.57 Billion USD | 42.73% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -37332.452% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -158015.942% |
| Molecular Templates, Inc. | 31.17 Million USD | -8300.115% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -15239.192% |
| Travere Therapeutics, Inc. | 588.1 Million USD | -345.228% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -2003.048% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -9443.317% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -7082.357% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -4606.39% |
| MacroGenics, Inc. | 154.2 Million USD | -1597.977% |
| RenovoRx, Inc. | 4.46 Million USD | -58529.646% |
| Adicet Bio, Inc. | 37.12 Million USD | -6953.879% |
| Prime Medicine, Inc. | 60.78 Million USD | -4207.996% |
| Aditxt, Inc. | 28.53 Million USD | -9077.207% |
| Adagene Inc. | 45.16 Million USD | -5696.852% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -1448923.525% |
| Quantum-Si incorporated | 26.63 Million USD | -9732.151% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | -275.362% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -85962.559% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -2177.642% |
| SciSparc Ltd. | 1.59 Million USD | -164063.009% |
| Vericel Corporation | 127.7 Million USD | -1950.35% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -46952.109% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -2967.547% |
| Generation Bio Co. | 171.63 Million USD | -1425.607% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -22570.13% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -6159.473% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -936.178% |
| Invivyd, Inc. | 51.71 Million USD | -4963.33% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -2746.799% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -40150.561% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -3368.263% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -256354.456% |
| 2seventy bio, Inc. | 310.12 Million USD | -744.302% |
| ADMA Biologics, Inc. | 193.97 Million USD | -1249.858% |
| Clene Inc. | 38.95 Million USD | -6622.292% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -7146.589% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -918.928% |
| GeoVax Labs, Inc. | 3.51 Million USD | -74288.878% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -1276.2% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -21398.134% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -1220.277% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -21371.447% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -5342.414% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -4855.243% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -607.955% |
| Evaxion Biotech A/S | 17.61 Million USD | -14762.512% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -1527.053% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -1609.295% |
| Trevena, Inc. | 48.26 Million USD | -5325.386% |
| Surrozen, Inc. | 8.14 Million USD | -32047.33% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -12025.029% |
| Cingulate Inc. | 10.36 Million USD | -25172.021% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -95114.545% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -6921.345% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -72906.703% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -19811.787% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -725.47% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -10437.245% |
| Clearmind Medicine Inc. | 3.61 Million USD | -72431.695% |
| Kronos Bio, Inc. | 54.2 Million USD | -4730.907% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -5465.972% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -11404.529% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -12945.688% |
| Statera Biopharma, Inc. | 22.67 Million USD | -11446.779% |
| ImmunityBio, Inc. | 1.09 Billion USD | -140.134% |
| Korro Bio, Inc. | 51.75 Million USD | -4959.515% |
| Kineta, Inc. | 7.22 Million USD | -36155.885% |
| BioVie Inc. | 9.7 Million USD | -26887.888% |
| Codexis, Inc. | 49.94 Million USD | -5142.462% |
| Celularity Inc. | 102.92 Million USD | -2443.889% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -2620.5% |
| Celcuity Inc. | 51.45 Million USD | -4989.205% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -758429.986% |
| Cibus, Inc. | 206.11 Million USD | -1170.346% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -6064.567% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -9841.152% |
| IN8bio, Inc. | 8.77 Million USD | -29749.521% |
| Kodiak Sciences Inc. | 213.59 Million USD | -1125.894% |
| Annexon, Inc. | 47.11 Million USD | -5457.112% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -2824.247% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -2616.972% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -19027.767% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | -0.577% |
| Eyenovia, Inc. | 19.78 Million USD | -13137.426% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -1378.604% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -33989.311% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -10765.181% |
| Arcellx, Inc. | 339.75 Million USD | -670.68% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -21907.06% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -966.384% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -27280.529% |
| Moolec Science SA | 13.94 Million USD | -18676.143% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -5967.853% |
| Geron Corporation | 146.12 Million USD | -1691.866% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -5081.667% |
| Royalty Pharma plc | 6.29 Billion USD | 58.422% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -6482.864% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -889284.048% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -106326.824% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -1284.254% |
| Humacyte, Inc. | 114.67 Million USD | -2183.283% |
| Structure Therapeutics Inc. | 29.05 Million USD | -8913.113% |
| 89bio, Inc. | 59.96 Million USD | -4266.693% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -9794.57% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -218829.766% |
| Genelux Corporation | 8.42 Million USD | -30997.387% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -38091.365% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -1820.789% |
| Notable Labs, Ltd. | 4.42 Million USD | -59046.149% |
| Liquidia Corporation | 73.13 Million USD | -3480.081% |
| Mustang Bio, Inc. | 17.61 Million USD | -14761.229% |
| Immunovant, Inc. | 48.95 Million USD | -5248.585% |
| Quantum-Si incorporated | 26.63 Million USD | -9732.151% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -6721.77% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -84282.855% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -3445.037% |
| Acasti Pharma Inc. | 11.55 Million USD | -22556.399% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -11481.879% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -96221.153% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -7000.361% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -192027.921% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -42852.756% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -10443.185% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -11193.996% |
| PepGen Inc. | 34.63 Million USD | -7460.856% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -21461.265% |
| United Therapeutics Corporation | 1.18 Billion USD | -121.485% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -37391.409% |
| Solid Biosciences Inc. | 38.45 Million USD | -6708.466% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -30498.819% |
| Immuneering Corporation | 12 Million USD | -21704.818% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -834162.628% |
| Silo Pharma, Inc. | 1.56 Million USD | -166754.652% |
| Belite Bio, Inc | 4.21 Million USD | -62080.005% |
| XOMA Corporation | 145.58 Million USD | -1698.599% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -107741.845% |
| Bionomics Limited | 10.15 Million USD | -25674.898% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -12083.705% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -11327.574% |
| uniQure N.V. | 624.01 Million USD | -319.603% |
| Cassava Sciences, Inc. | 14.19 Million USD | -18345.932% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -1448923.525% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -1438.57% |
| Forte Biosciences, Inc. | 3.66 Million USD | -71323.895% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -1004723.799% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -38708.359% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -33989.311% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -14962.993% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -24676.684% |
| Altimmune, Inc. | 16.54 Million USD | -15729.756% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | -323.891% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -11327.574% |
| Compugen Ltd. | 55.77 Million USD | -4594.576% |
| Peak Bio, Inc. | 20.75 Million USD | -12516.75% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -2270.386% |
| Benitec Biopharma Inc. | 4.96 Million USD | -52669.045% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -1558.864% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -3383.119% |
| Zura Bio Limited | 21.29 Million USD | -12197.577% |
| PolyPid Ltd. | 17.46 Million USD | -14889.695% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -2229.558% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -3383.119% |
| Instil Bio, Inc. | 99.8 Million USD | -2523.621% |
| argenx SE | 444.95 Million USD | -488.469% |
| Immunome, Inc. | 28.65 Million USD | -9036.716% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -31306.981% |
| Verona Pharma plc | 58.84 Million USD | -4349.958% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -17991.619% |
| Shattuck Labs, Inc. | 14.85 Million USD | -17521.643% |
| CervoMed Inc. | 2.59 Million USD | -100772.697% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -53621.789% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -20459.045% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -24754.295% |
| Moolec Science SA | 13.94 Million USD | -18676.143% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -111630.127% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -4609.751% |
| AnaptysBio, Inc. | 364.28 Million USD | -618.776% |
| Design Therapeutics, Inc. | 11.95 Million USD | -21800.301% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -20543.33% |
| NeurAxis, Inc. | 1.91 Million USD | -136792.697% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -6626.264% |
| Lumos Pharma, Inc. | 13.33 Million USD | -19538.491% |
| Achilles Therapeutics plc | 19.08 Million USD | -13618.238% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -17991.619% |
| 180 Life Sciences Corp. | 5.38 Million USD | -48504.017% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -11000.564% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -11404.529% |
| Nutriband Inc. | 1.07 Million USD | -242587.357% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -8457.422% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -17944.242% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | -552.522% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -7963.314% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -19965.758% |
| Palisade Bio, Inc. | 2.73 Million USD | -95496.933% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -49745.802% |
| Beam Therapeutics Inc. | 478.38 Million USD | -447.342% |
| Neurogene Inc. | 36.54 Million USD | -7064.081% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | -557.97% |
| AEON Biopharma, Inc. | 159.88 Million USD | -1537.636% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -5395.068% |
| Sesen Bio, Inc. | 30.98 Million USD | -8350.813% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -9985.898% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -34342.589% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -1237.707% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -1263.345% |
| Athira Pharma, Inc. | 30.05 Million USD | -8611.448% |
| Vaccinex, Inc. | 5.94 Million USD | -43965.971% |
| HCW Biologics Inc. | 15.05 Million USD | -17295.761% |
| XOMA Corporation | 145.58 Million USD | -1698.599% |
| Nektar Therapeutics | 267.04 Million USD | -880.505% |
| Arvinas, Inc. | 644.6 Million USD | -306.205% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -14665.583% |
| Merus N.V. | 102.15 Million USD | -2463.264% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -1689.136% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -2652.733% |
| Rezolute, Inc. | 11.73 Million USD | -22214.641% |
| Clene Inc. | 38.95 Million USD | -6622.292% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -91858.221% |
| BeyondSpring Inc. | 48.26 Million USD | -5324.6% |
| Synlogic, Inc. | 32.89 Million USD | -7859.872% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -17818.292% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -160144.798% |
| Peak Bio, Inc. | 20.75 Million USD | -12516.75% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -4026.129% |
| Krystal Biotech, Inc. | 39.71 Million USD | -6493.141% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -595.192% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -2529.734% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -604994.217% |
| MannKind Corporation | 721.36 Million USD | -262.978% |
| Ikena Oncology, Inc. | 22.33 Million USD | -11623.304% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -125422.531% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -2452.296% |
| Gossamer Bio, Inc. | 249.14 Million USD | -950.946% |
| CohBar, Inc. | 1.03 Million USD | -253218.86% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -24396.211% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -13646.325% |
| Legend Biotech Corporation | 589.93 Million USD | -343.847% |
| Mural Oncology plc | 37.92 Million USD | -6803.607% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -1874.125% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -113975.001% |
| Disc Medicine, Inc. | 22.87 Million USD | -11346.557% |
| Champions Oncology, Inc. | 28.03 Million USD | -9239.754% |
| REGENXBIO Inc. | 262.22 Million USD | -898.52% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -77843.603% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -20790.378% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -19394.288% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -12248.031% |
| Vaxart, Inc. | 34.02 Million USD | -7595.518% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -12742.053% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -9077.103% |
| Cellectis S.A. | 249.57 Million USD | -949.144% |
| Longeveron Inc. | 5.33 Million USD | -48961.27% |
| Repare Therapeutics Inc. | 41.81 Million USD | -6161.269% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | -8.862% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -4237.397% |
| Revolution Medicines, Inc. | 262.39 Million USD | -897.877% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -124171.476% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -30254.741% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -22087.95% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -18545.589% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -121629.428% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 49.155% |
| Denali Therapeutics Inc. | 122.96 Million USD | -2029.421% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -46952.109% |
| Veru Inc. | 32.81 Million USD | -7879.836% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -38019.086% |
| Cingulate Inc. | 10.36 Million USD | -25172.021% |
| Passage Bio, Inc. | 39.26 Million USD | -6569.044% |
| Context Therapeutics Inc. | 4.19 Million USD | -62366.079% |
| Exicure, Inc. | 8.54 Million USD | -30528.144% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -8773.526% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -24870.437% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -11779.679% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -1506.518% |
| Nuvalent, Inc. | 31.82 Million USD | -8128.011% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -41059.282% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -4054.74% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -14446.667% |
| OmniAb, Inc. | 87.4 Million USD | -2895.881% |
| Anew Medical, Inc. | 8.24 Million USD | -31669.763% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -6738.501% |
| Lipocine Inc. | 2.63 Million USD | -99397.308% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -9866.504% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -6411.489% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -9728.16% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -2939.209% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -48379.911% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -3064.344% |
| Ocugen, Inc. | 23.98 Million USD | -10817.733% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -5542.252% |
| Q32 Bio Inc. | 233.12 Million USD | -1023.16% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -28781.535% |
| Alumis Inc. Common Stock | 53.5 Million USD | -4794.023% |
| Equillium, Inc. | 27.95 Million USD | -9265.812% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -1167.426% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -46435.559% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -42593.847% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -1564.315% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -3671.117% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -26151.727% |
| Dominari Holdings Inc. | 4.63 Million USD | -56391.909% |
| Edesa Biotech, Inc. | 1.84 Million USD | -142077.856% |
| vTv Therapeutics Inc. | 29.56 Million USD | -8755.819% |
| Bio-Techne Corporation | 744.34 Million USD | -251.775% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -1976.464% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -660.155% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -6353.235% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -8942.373% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -2734.994% |
| Nkarta, Inc. | 105.6 Million USD | -2379.545% |
| BioCardia, Inc. | 4.59 Million USD | -56945.752% |
| Iterum Therapeutics plc | 32.66 Million USD | -7916.655% |